Cannabis use in the UK: a quantitative comparison of individual differences in medical and recreational cannabis users.
anxiety
cannabinoid
cannabis
depression
medical cannabis
recreational drug use
Journal
Frontiers in psychology
ISSN: 1664-1078
Titre abrégé: Front Psychol
Pays: Switzerland
ID NLM: 101550902
Informations de publication
Date de publication:
2023
2023
Historique:
received:
17
08
2023
accepted:
05
12
2023
medline:
23
1
2024
pubmed:
23
1
2024
entrez:
23
1
2024
Statut:
epublish
Résumé
There is a paucity of research, especially in the UK, that investigates individual differences in both medical and recreational cannabis users. A cross-sectional survey study design was used to assess recreational cannabis users and medical cannabis users currently living in the UK. Recreational cannabis users were invited to take part via social media. Medical cannabis users were recruited from Sapphire Medical Clinics, London, UK, which provides treatment with prescribed cannabis-based medicinal products. Demographic data and cannabis use frequency, as well as post-traumatic stress disorder symptoms (PCL-5), depression symptoms (Centre for Epidemiological Studies Depression Scale), trait and state anxiety (State-Trait Anxiety Inventory), and cannabis use motives [Comprehensive Marijuana Motives Questionnaire (CMMQ)] were collected. The Chi-square and independent-sample
Identifiants
pubmed: 38259543
doi: 10.3389/fpsyg.2023.1279123
pmc: PMC10802163
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1279123Informations de copyright
Copyright © 2024 Ciesluk, Erridge, Sodergren and Troup.
Déclaration de conflit d'intérêts
SE is the Head of Research at Sapphire Medical Clinics. MS is the Chief Medical Officer of Curaleaf International. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.